Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...
Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...
The likely next secretary of Health and Human Services scared me with a cruel and misleading statement—and that’s the danger ...
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...
Bobby saw skepticism of vaccines as a way to generate attention and controversy for himself, get book deals [and] lucrative ...
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...
News Medical on MSN3d
Neoantigen vaccine sparks powerful immune defense against kidney cancerA personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...
All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...
and I think the science and the effectiveness of this drug is proven," Davis said. "It is truly seen globally as an anti-cancer vaccine. It's one of the only ones out there." ...
"I am not anti-vaccine." -- Robert F. Kennedy Jr., President Donald Trump's nominee for HHS secretary, attempting to allay Senators' concerns about his anti-vaccine advocacy during a confirmation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback